A highly sensitive diagnostic assay for aggregate-related diseases, including prion diseases and Alzheimer's disease

Rejuvenation Research

Volumn 11, Issue 2, 2008, Pages 359-363

  Birkmann, Eva ^a,b   Henke, Franziska ^b   Funke, Susanne Aileen ^a   Bannach, Oliver ^b   Riesner, Detlev ^b   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SENSITIVITY ANALYSIS; SURFACE FLUORESCENCE INTENSITY DISTRIBUTION ANALYSIS;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL ASSAY; CATTLE; PRION DISEASES; PROTEIN STRUCTURE, QUATERNARY; SENSITIVITY AND SPECIFICITY;

EID: 42649099631     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2008.0697     Document Type: Article

References (11)

1. Hallen A. Accumulation of insoluble protein and aging. Biogerontology 2002;3:307-316.
2. Hallen A. Gompertz law and aging as exclusion effects. Biogerontology 2007;8:595-603.
3. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272: 20313-20316.
4. Kimura T, Takamatsu J, Miyata T, Miyakawa T, Horiuchi S. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl) lysine and pentosidine, in age-related inclusions in human brains. Pathol Int 1998;48:575-579.
5. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49-60.
6. Weber T, Aguzzi A. The spectrum of transmissible spongiform encephalopathies. Intervirology 1997;40: 198-212.
7. Birkmann E, Henke F, Weinmann N, Dumpitak C, Groschup M, Funke A, Willbold D, Riesner D. Counting of single prion particles bound to a capture-antibody surface (surface-FIDA). Vet Microbiol 2007;123: 294-304.
8. Kask P, Palo K, Fay N, Brand L, Mets U, Ullmann D, Jungmann J, Pschorr J, Gall K. Two-dimensional fluorescence intensity distribution analysis: theory and applications. Biophys J 2000;78:1703-1713.
9. Funke SA, Birkmann E, Henke F, Gortz P, Lange-Asschenfeldt C, Riesner D, Willbold D. Single particle detection of Abeta aggregates associated with Alzheimer's disease. Biochem Biophys Res Commun 2007; 364:902-907.
10. Krasemann S, Jurgens T, Bodemer W. Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy. J Biotechnol 1999;73:119-129.
11. Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FE, et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol 1997;273:614-622.